Invention Grant
- Patent Title: Glycopegylated erythropoietin formulations
- Patent Title (中): 糖基化促红细胞生成素制剂
-
Application No.: US11440839Application Date: 2006-05-25
-
Publication No.: US07842661B2Publication Date: 2010-11-30
- Inventor: Shawn DeFrees , Robert J. Bayer , David A. Zopf , Jichao Kang , Walter Scott Willett
- Applicant: Shawn DeFrees , Robert J. Bayer , David A. Zopf , Jichao Kang , Walter Scott Willett
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agency: Leydig, Voit & Mayer, Ltd.
- Main IPC: C07K14/00
- IPC: C07K14/00 ; C07K14/505 ; A61K38/00 ; A61K38/16

Abstract:
The present invention provides conjugates between erythropoietin and PEG moieties. The conjugates are linked via an intact glycosyl linking group interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from glycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto a glycosyl residue on the peptide. Also provided are methods for preparing the conjugates, methods for treating various disease conditions with the conjugates, and pharmaceutical formulations including the conjugates.
Public/Granted literature
- US20060287224A1 Glycopegylated erythropoietin formulations Public/Granted day:2006-12-21
Information query